Recent Publications
- Choi J, et al.
Diabetes Care. 2024 Jun 28:dc240022. doi: 10.2337/dc24-0022. Online ahead of print.
- Khurana S, Varma D, Foltz DR.
Mol Cell Biol. 2024;44(6):209-225. doi: 10.1080/10985549.2024.2350543. Epub 2024 May 23.
- Watanabe J, et al. Among authors: hashizume r.
J Clin Invest. 2024 May 21:e174794. doi: 10.1172/JCI174794. Online ahead of print.
Susceptibility to innate immune activation in genetically-mediated myocarditis.
Selgrade DF, et al. Among authors: mcnally em.J Clin Invest. 2024 May 16:e180254. doi: 10.1172/JCI180254. Online ahead of print.
Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias.
Ohiri JC, et al. Among authors: mcnally em.J Am Heart Assoc. 2024 May 21;13(10):e030467. doi: 10.1161/JAHA.123.030467. Epub 2024 May 18.
Signaling by Type I Interferons in Immune Cells: Disease Consequences.
Zannikou M, Fish EN, Platanias LC.Cancers (Basel). 2024 Apr 22;16(8):1600. doi: 10.3390/cancers16081600.
Hijacked enhancer-promoter and silencer-promoter loops in cancer.
Wang X, Yue F.Curr Opin Genet Dev. 2024 Jun;86:102199. doi: 10.1016/j.gde.2024.102199. Epub 2024 Apr 25.
- Long AM, et al. Among authors: mcnally em.
Matrix Biol. 2024 May;129:44-58. doi: 10.1016/j.matbio.2024.04.001. Epub 2024 Apr 4.
Timing and Implementation of Viral Gene Therapy for Cardiomyopathy.
McNally EM.JACC Heart Fail. 2024 Apr;12(4):771-775. doi: 10.1016/j.jchf.2024.01.020.
- Gold S, Shilatifard A.
Curr Opin Genet Dev. 2024 Jun;86:102181. doi: 10.1016/j.gde.2024.102181. Epub 2024 Apr 2.